ATBECHDEDKESFRGBGRITLILUNLSEMCPTIE......FI....CY................................*JDIM350 (Ver 2.1 Jan 2001) 2999001/01185712CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120051019W10000000073DEBibliographieENBibliographyFRBibliographieEP00936827.5200005252001122820030707enenen136743 P19990528US20051019200542200203132002112005081720053320040825200510192005427 7C 12Q 1/70 A 7C 12Q 1/68 B 7A 61K 31/44 B 7A 61K 31/505 B 7A 61P 31/18 B 7G 06F 19/00 BdeNEUE MUTATIONSPROFILE DER HIV-1 REVERSE TRANSCRIPTASE IN VERBINDUNG MIT PHÄNOTYPISCHEM MEDIKAMENTRESISTENZenNEW MUTATIONAL PROFILES IN HIV-1 REVERSE TRANSCRIPTASE CORRELATED WITH PHENOTYPIC DRUG RESISTANCEfrNOUVEAUX PROFILS MUTATIONNELS DANS LA TRANSCRIPTASE INVERSE DU VIH-1 EN RELATION AVEC UNE PHARMACORESISTANCE PHENOTYPIQUEWO-A-97/27332LARDER B ET AL: "A complete survey in over 1,500 clinical HIV-1 isolates of phenotypic and genotypic protease resistance profiles and their relation to therapy history" AIDS, vol. 12, no. suppl. 4, November 1998 (1998-11), page S11 XP000952507HERTOGS K ET AL: "Comprehensive HIV drug resistance monitoring using rapid, high-throughput phenotypic and genotypic assays with correlative data analysis" AIDS, vol. 12, no. suppl. 4, November 1998 (1998-11), page S11 XP000952505LARDER B: "Reverse transcriptase inhibitors" AIDS, vol. 12, no. suppl. 4, 1998, page S3 XP000952508LARDER B ET AL: "Closing in on drug resistance" NATURE STRUCTURAL BIOLOGY, vol. 6, no. 2, February 1999 (1999-02), pages 103-106, XP000946885HERTOGS K ET AL: "A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs" ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 42, no. 2, February 1998 (1998-02), pages 269-76, XP000946883MILLER V ET AL: "Patterns of resistance and cross-resistance to human immunodeficiency virus type 1 reverse transcriptase inhibitors in patients treated with nonnucleoside transcriptase inhibitors " ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 42, no. 12, December 1998 (1998-12), pages 3123-29, XP000952614WINTERS M ET AL: "A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors" JOURNAL OF CLINICAL INVESTIGATION, vol. 102, November 1998 (1998-11), pages 1769-75, XP000952589SCHINAZI R ET AL: "Mutations in retroviral genes associated with drug resistance" INTERNATIONAL VIRAL NEWS, vol. 5, no. 8, - 1997 pages 129-42, XP000861634IVERSEN A ET AL: "Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy" JOURNAL OF VIROLOGY, vol. 70, no. 2, February 1996 (1996-02), pages 1086-90, XP002150115CONDRA J ET AL: "Genetic correlation of in vivo viral isolates to indinavir, a human immunodeficiency type 1 protease inhibitor" JOURNAL OF VIROLOGY, vol. 70, no. 12, December 1996 (1996-12), pages 8270-76, XP002150116HERTOGS, KurtQuinten Matsijslei 11/42B-2018 AntwerpenBELARDER, BrendanMonona 6, ChurchlaneCambridge CB37HQGBPAUWELS, Rudi, Wilfried, JanBerentrodedreef 27B-2820 BonheidenBEVIRCO BVBA04337280VIP-2-EPO/PCTGeneraal De Wittelaan L 11 B42800 MechelenBEDaelemans, Frank F.R.00091904Tibotec-Virco N.V., General De Wittelaan L11 B3B-2800 MechelenBEATBECHCYDEDKESFIFRGBGRIEITLILUMCNLPTSEEP200000491520000525enWO200007351120001207200049